US OptionsDetailed Quotes
ACB250103C2500
- 0.00
- 0.000.00%
15min DelayTrading Jan 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-46.64%PremiumJan 3, 2025Expiry Date2.19Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Aurora Cannabis Stock Discussion
https://youtu.be/GQ7KnBOaFOU?si=AkPe7GGfovqKWeG5
1. NFA (Not Financial Advice!)
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours); PM (pre market)
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. It’s 2025, those newbies need...
$Aurora Cannabis (ACB.US)$
$Femto Technologies (BCAN.US)$
$Canopy Growth (CGC.US)$
$Hempacco (HPCO.US)$
$IM Cannabis (IMCC.US)$
$Leafly (LFLY.US)$
$Tilray Brands (TLRY.US)$
$cbdMD (YCBD.US)$
Aurora Cannabis Expands Innovative Recreational Product Portfolio
Aurora Cannabis (NASDAQ: ACB) announces expansion of its recreational product portfolio with new offerings across Greybeard, San Rafael '71, and Tasty's brands. The new lineup includes Greybeard's Banana Gas Pure Live Resin Vape, Country Lemon Terp Slush, and Critical Diesel Pre-Rolls; San Rafael '71's 20 Pack Pre-Rolls; and Tasty's Diamond Infused Pre-Rolls in Mango, Honeydew, and Melon varieties, pl...
$Canopy Growth (CGC.US)$ $Flora Growth (FLGC.US)$ $Akanda (AKAN.US)$ $IM Cannabis (IMCC.US)$ $Leafly (LFLY.US)$ $Femto Technologies (BCAN.US)$ $cbdMD (YCBD.US)$ $Hempacco (HPCO.US)$ $Aurora Cannabis (ACB.US)$
Legislative Committee In Ireland Calls For Marijuana Legalization And Decriminalization Of 'All Illicit Drugs'" - Marijuana Moment
Benzinga· 2 mins ago
After lawmakers in Ireland delayed a vote on marijuana legalization earlier this year in favor of further studying the issue, a special legislative committee on drug policy has published an interim report with nearly 60 re...
No comment yet